Last reviewed · How we verify
NCT04549714: AI-ablation
Quantitative Ablation of Pulmonary Vein Vestibule in Paroxysmal Atrial Fibrillation.
NA trial testing High AI in paroxysmal atrial fibrillation in Atrial Fibrillation in 90 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Yuehui Yin |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 7 June 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 August 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- High AI in paroxysmal atrial fibrillation
- Middle AI in paroxysmal atrial fibrillation
- Low AI in paroxysmal atrial fibrillation
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Arrythmia — all drugs for Arrythmia →
Sponsor
Yuehui Yin
Who can join
Adults 18 to 80, any sex, with Atrial Fibrillation or Arrythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trial is to explore the optimal AI value for isolating the pulmonary veins and achieving left ventricular apex and mitral isthmus block. Patients with atrial fibrillation who are scheduled to undergo catheter ablation will be randomized to different groups, then every group receive circumferential pulmonary vein isolation with different AI values. The relevant indicators such as the proportion of pulmonary vein single-circle isolation, operation time, the incidence of complications, and the proportion of recurrence of atrial fibrillation and other atrial arrhythmias after 1 year were collected.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04549714
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Yuehui Yin trials
Trials by the same sponsor.
- NCT07380620 — Stepwise Strategy for Treatment of Atrial Fibrillation Substrate Extended Study · enrolling by invitation
- NCT07129564 — Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04549714 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuehui Yin
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04549714.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing